Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Cells|February 25, 2022
Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. <i>Cells</i> 2021, <i>10</i>, 38Walter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.Cells|January 1, 2021
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGFWalter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.The Journal of Clinical Endocrinology and Metabolism|April 19, 2007
Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasiaGuido Rindi, Lisa Licini, Vittorio Necchi, et al.Cell and Tissue Research|November 13, 2019
VGF peptides as novel biomarkers in Parkinson's diseaseCristina Cocco, Giulia Corda, Carlo Lisci, et al.Plos One|July 19, 2012
NPY and VGF immunoreactivity increased in the arcuate nucleus, but decreased in the nucleus of the Tractus Solitarius, of type-II diabetic patientsNadia Saderi, Roberto Salgado-Delgado, Rafael Avendaño-Pradel, et al.International Journal of Molecular Sciences|September 25, 2019
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy BodiesInger van Steenoven, Barbara Noli, Cristina Cocco, et al.Plos One|August 30, 2019
Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21Carlo Lisci, Jo E Lewis, Zoe C T R Daniel, et al.Plos One|October 14, 2016
VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model StudiesCarla Brancia, Barbara Noli, Marina Boido, et al.Frontiers in Immunology|June 29, 2023
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosusCristina Cocco, Elias Manca, Giulia Corda, et al.Journal of Experimental & Clinical Cancer Research : CR|June 16, 2019
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinomaFederica Giordano, Valentina Vaira, Diego Cortinovis, et al.Pageof 5